Discover who can file for the Ozempic lawsuit, now centered on claims of gastroparesis and intestinal blockages. Understand the criteria for legal action.
Learn about the implications of the recent GLP-1 RA lawsuit merger for Ozempic & Wegovy claimants and how this consolidation affects cases and claimant actions.
Ozempic Label Update: Warning of Intestinal Blockage Risk September 27, 2023 – Ozempic and the Risk of Intestinal Blockage On September 27, 2023, a significant update was announced for Ozempic, a medication primarily used for type 2 diabetes and off-label for weight loss. The drug’s labeling is now revised to include warnings about the risk […]
FDA Documents Reveal Potential Risk of Intestinal Obstruction with GLP-1 Drugs, Sparking Legal Concerns Serious Warning Issued to Drug Manufacturers Following Levensten Law Firm FOIA Request The Levensten Law Firm, through its diligent use of the Freedom of Information Act (FOIA), has acquired internal FDA documents raising concerns about the safety of popular GLP-1 drugs […]